Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V M Hirsch

Showing results (91-100 of 96) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 96 results.
Advances in Experimental Medicine and Biology|January 1, 1996
Host range restricted, non-replicating vaccinia virus vectors as vaccine candidatesB Moss, M W Carroll, L S Wyatt, et al.
Journal of Virology|May 3, 2001
Reduction of simian-human immunodeficiency virus 89.6P viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccinationD H Barouch, S Santra, M J Kuroda, et al.
Journal of Virology|February 23, 2000
Containment of simian immunodeficiency virus infection: cellular immune responses and protection from rechallenge following transient postinoculation antiretroviral treatmentJ D Lifson, J L Rossio, R Arnaout, et al.
Journal of Virology|October 3, 2001
Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatmentJ D Lifson, J L Rossio, M Piatak, et al.
Journal of Virology|February 13, 2001
Elicitation of high-frequency cytotoxic T-lymphocyte responses against both dominant and subdominant simian-human immunodeficiency virus epitopes by DNA vaccination of rhesus monkeysD H Barouch, A Craiu, S Santra, et al.
Mucosal Immunology|May 31, 2012
Loss of mucosal CD103+ DCs and IL-17+ and IL-22+ lymphocytes is associated with mucosal damage in SIV infectionN R Klatt, J D Estes, X Sun, et al.
Pageof 10

Showing results (91-100 of 96) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 96 results.
Advances in Experimental Medicine and Biology|January 1, 1996
Host range restricted, non-replicating vaccinia virus vectors as vaccine candidatesB Moss, M W Carroll, L S Wyatt, et al.
Journal of Virology|May 3, 2001
Reduction of simian-human immunodeficiency virus 89.6P viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccinationD H Barouch, S Santra, M J Kuroda, et al.
Journal of Virology|February 23, 2000
Containment of simian immunodeficiency virus infection: cellular immune responses and protection from rechallenge following transient postinoculation antiretroviral treatmentJ D Lifson, J L Rossio, R Arnaout, et al.
Journal of Virology|October 3, 2001
Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatmentJ D Lifson, J L Rossio, M Piatak, et al.
Journal of Virology|February 13, 2001
Elicitation of high-frequency cytotoxic T-lymphocyte responses against both dominant and subdominant simian-human immunodeficiency virus epitopes by DNA vaccination of rhesus monkeysD H Barouch, A Craiu, S Santra, et al.
Mucosal Immunology|May 31, 2012
Loss of mucosal CD103+ DCs and IL-17+ and IL-22+ lymphocytes is associated with mucosal damage in SIV infectionN R Klatt, J D Estes, X Sun, et al.
Pageof 10